Drosophila Toxicogenomics: genetic variation and sexual dimorphism in susceptibility to 4-Methylimidazole

Katelynne M. Collins,Elisabeth Howansky,Sarah C. Macon-Foley,Maria E. Adonay,Vijay Shankar,Richard F. Lyman,Nestor Octavio Nazario-Yepiz,Jordyn K. Brooks,Rachel A. Lyman,Trudy F. C. Mackay,Robert R. H. Anholt
DOI: https://doi.org/10.1186/s40246-024-00689-3
2024-11-05
Human Genomics
Abstract:4-methylimidazole is a ubiquitous and potentially carcinogenic environmental toxicant. Genetic factors that contribute to variation in susceptibility to its toxic effects are challenging to assess in human populations. We used the Drosophila melanogaster Genetic Reference Panel (DGRP), a living library of natural genetic variation, to identify genes with human orthologs associated with variation in susceptibility to 4-methylimidazole.
genetics & heredity
What problem does this paper attempt to address?